Integrating Adjuvant CDK4/6 Therapy for HR+/Her2- EBC | Dr. Naresh Somani | Oncology 2024

(17:47)

Adjuvant/Neoadjuvant Therapy for Breast Cancer: Updates and Molecular Predictors of Benefit

(38:22)

Integrating Perioperative Immunotherapy Strategies in NSCLC

(5:15)

Adjuvant therapy in RCC: harnessing prognostic information

(2:35)

RCC: Applying Adjuvant Therapy Data From Clinical Trials

(5:58)

Current Status of Adjuvant Therapy for NSCLC

(23:42)

Adjuvant Treatment for Early Stage Hormone Positive Breast Cancer: Role of Genomic Signatures

(30:56)

What is Adjuvant Therapy?

(1:)

Dr Hauschild on the Role of Adjuvant/Neoadjuvant Therapy in Melanoma Management

(2:15)

Pancreatic Cancer Adjuvant Therapy

(5:41)

Attempts to integrate novel targeted agents and immunotherapy into the combined modality paradigm

(19:33)

Molecular Testing and Implications for Adjuvant Therapy in Early Stage NSCLC

(24:45)

S1 Episode 4: Managing Lung Cancer With Neoadjuvant and Adjuvant Therapy

(24:30)

Adjuvant Therapy Considerations, According to Drs. Brian Rini and Monty Pal

(6:32)

Adjuvant Therapy for Early-Stage HER2-Positive Breast Cancer

(1:5:31)

Precision Oncology in Early-Stage Lung Cancer, With Adjuvant EGFR-Targeted Therapy Leading the Way

(59:19)

Adjuvant RCC Treatment Considerations and Final Thoughts on RCC Therapy

(4:2)

Neoadjuvant and Adjuvant Chemotherapy | Part II: Clinical Studies, Side Effects \u0026 Future

(19:52)

How to Integrate Perioperative Immunotherapy Into Multimodal Treatment Plans in Resectable NSCLC

(49:11)